AR085172A1 - SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES - Google Patents

SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES

Info

Publication number
AR085172A1
AR085172A1 ARP110101411A ARP110101411A AR085172A1 AR 085172 A1 AR085172 A1 AR 085172A1 AR P110101411 A ARP110101411 A AR P110101411A AR P110101411 A ARP110101411 A AR P110101411A AR 085172 A1 AR085172 A1 AR 085172A1
Authority
AR
Argentina
Prior art keywords
substituted
methyl
formula
inhibitors
alkyl
Prior art date
Application number
ARP110101411A
Other languages
Spanish (es)
Inventor
Dr Bretschneider Thomas
Hungenberg Heike
Dr Flein Martin
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Priority to ARP110101411A priority Critical patent/AR085172A1/en
Publication of AR085172A1 publication Critical patent/AR085172A1/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Los compuestos de la presente poseen propiedades insecticidas y acaricidas eficaces contra parásitos animales. Reivindicación 1: Combinaciones de principios activos que contienen al menos un compuesto, y preferentemente exactamente uno, de la fórmula (1), en la que (la) G¹ representa N, CH o C-halógeno, G² representa un resto de fórmula (A), en la que R¹ representa hidrógeno o alquilo y G³ representa heterociclilo dado el caso sustituido, heteroarilo dado el caso sustituido o arilo dado el caso sustituido o (Ib) G¹ representa N o C-halógeno, G² representa el resto de fórmula (B), en la que G³ representa heterociclilo dado el caso sustituido, heteroarilo dado el caso sustituido o arilo dado el caso sustituido, o (Ic) G¹ representa CH, G² representa el resto de fórmula (B), en la que G³ representa heterociclilo dado el caso sustituido o furanilo dado el caso sustituido o representa tienilo sustituido con halógeno, nitro, amino, alquilamino, dialquilamino, haloalquilo, cicloalquilalquilo, alcoxi, haloalcoxi, alquiltio, alcoxialquilo, bis(alcoxi)alquilo, alcoxicarbonilo, a-hidroximino-alcoxicarbonilmetilo, a-alcoximino-alcoxicarbonilmetilo, C(X)NR²R³ (en el que X representa oxígeno o azufre, R² representa hidrógeno o alquilo y R³ representa alquilo, haloalquilo, alcoxi, cianoalquilo, alquinilo, cicloalquilo, cicloalquilalquilo, alcoxialquilo, alquiltioalquilo o arilalquilo o R² y R³, conjuntamente con el átomo de nitrógeno al que están unidos, forman un anillo), alquilsulfinilo, alquilsulfonilo, heterociclilo, arilo (que, a su vez, puede estar sustituido con halógeno, ciano, nitro, alquilo y haloalquilo), heteroarilo (que, a su vez, puede estar sustituido con halógeno, nitro, alquilo, haloalquilo, alcoxi, haloalcoxi, alcoxialquilo, alquiltio, alquiltioalquilo y cicloalquilo), heteroarilalquilo (que, a su vez, puede estar sustituido con halógeno, nitro, alquilo, haloalquilo, alcoxi, haloalcoxi, alcoxialquilo, alquiltio, alquiltioalquilo y cicloalquilo), tienilo sustituido o representa hetarilo dado el caso sustituido en cada caso de la serie pirrolilo, pirazolilo, imidazolilo, 1,2,3-triazolilo, 1,2,4-triazolilo, oxazolilo, isoxazolilo, tiazolilo, isotiazolilo, 1,2,3-oxadiazolilo, 1,2,4-oxadiazolilo, 1,3,4-oxadiazolilo, 1,2,5-oxadiazolilo, 1,2,3-tiadiazolilo, 1,2,4-tiadiazolilo, 1,3,4-tiadiazolilo, 1,2,5-tiadiazolilo, piridilo, pirimidinilo, piridazinilo, pirazinilo, 1,2,3-triazinilo, 1,2,4-triazinilo, 1,3,5-triazinilo, benzofurilo, bencisofurilo, benzotienilo, bencisotienilo, indolilo, isoindolilo, indazolilo, benzotiazolilo, bencisotiazolilo, benzoxazolilo, bencisoxazolilo bencimidazolilo, 2,1,3-benzoxadiazol, quinolinilo, isoquinolinilo, cinnolinilo, ftalazinilo, quinazolinilo, quinoxalinilo, naftiridinilo, benzotriazinilo, purinilo, pteridinilo e indolizinilo o representa arilo sustituido con ciano, nitro, haloalcoxi o heterociclilo, o (Id) G¹ representa N, CH o C-halógeno, G² representa un resto de fórmula (C), en la que R¹ representa hidrógeno o alquilo y G³ representa heterociclilo dado el caso sustituido, heteroarilo dado el caso sustituido o arilo dado el caso sustituido, o así como sales, complejos metálicos y N-óxidos de los compuestos de fórmula (1), y uno o varios de otros principios activos del grupo (de la fórmula) (II) tal como se muestra a continuación: Inhibidores de la acetilcolinesterasa (AChE) [II-1]: (II-1.A) Carbamatos, por ejemplo, alanicarb, aldicarb, aldoxicarb, alixicarb, aminocarb, bendiocarb, benfuracarb, bufencarb, butacarb, butocarboxim, butoxicarboxim, carbarilo, carbofurano, carbosulfan, cloetocarb, dimetilan, etiofencarb, fenobucarb, fenotiocarb, formetanato, furatiocarb, isoprocarb, metam-sodio, metiocarb, metomilo, metolcarb, oxamilo, pirimicarb, promecarb, propoxur, tiodicarb, tiofanox, trimetacarb, XMC, xililcarb; (II-1.B) organofosfatos, por ejemplo, acefato, azametifos, (metil, etil) azinfos, etil bromofos, (metil) bromfenvinfos, butatiofos, cadusafos, carbofenotion, cloretoxifos, clorfenvinfos, clormefos, (metil, etil) clorpirifos, coumafos, cianofenfos, cianofos, clorfenvinfos, demeton-S-metilo, demeton-S-metilsulfona, dialifos, diazinon, diclofention, diclorvos/DDVP, dicrotofos, dimetoato, dimetilvinfos, di-oxabenzofos, disulfoton, EPN, etion, etoprofos, etrimfos, famfur, fenamifos, fenitrotion, fensulfotion, fention, flupirazofos, fonofos, formotion, fosmetilan, fostiazato, heptenofos, yodofenfos, iprobenfos, isazofos, isofenfos, isopropilo, O-salicilato, isoxation, malation, mecarbam, metacrifos, metamidofos, metidation, mevinfos, monocrotofos, naled, ometoato, metil oxidemeton, (metil, etil) paration, fentoato, forato, fosalon, fosmet, fosfamidon, fosfocarb, foxim, (metil, etil) pirimifos, profenofos, propafos, propetamfos, protiofos, protoato, piraclofos, piridafention, piridation, quinalfos, sebufos, sulfotep, sulprofos, tebupirimfos, temefos, terbufos, tetraclorvinfos, tiometon, triazofos, triclorfon, vamidotion; Antagonistas del canal de cloruro controlado por GABA [II-2]: (II-2.A) Organocloros, por ejemplo, canfecloro, clordano, endosulfan, g-HCH, HCH, heptacloro, lindano, metoxicloro; (II-2.B) Fiproles (fenilpirazoles), por ejemplo, acetoprol, etiprol, fipronilo, pirafluprol, piriprol, vaniliprol; Moduladores del canal de sodio / bloqueador del canal de sodio dependiente de la tensión [II-3]: (II-3) Piretroides, por ejemplo, acrinatrina, (d-cis-trans, d-trans) aletrina, b-ciflutrina, bifentrina, bioaletrina, isómero S-ciclopentil bioaletrina, bioetanometrina, biopermetrina, bioresmetrina, clovaportrina, cis-cipermetrina, cis-resmetrina, cis-permetrina, clocitrina, cicloprotrina, ciflutrina, cihalotrina, (a-, b-, q-, z-) cipermetrina, cifenotrina, deltametrina, empentrina (isómero 1R), esfenvalerato, eto-fenprox, fenflutrina, fenpropatrina, fenpiritrina, fenvalerato, flubrocitrinato, flucitrinato, flufenprox, flumetrina, fluvalinato, fub-fenprox, g-cihalotrina, imiprotrina, kadetrina, l-cihalotrina, metoflutrina, (cis-, trans-) permetrina, fenotrina (isómero 1R-trans), praletrina, proflutrina, protrifenbute, pires-metrina, resmetrina, RU 15525, silafluofen, t-fluvalinato, teflutrina, teraletrina, tetrametrina (isómero 1R), tralometrina, transflutrina, ZXI 8901, piretrina (piretrum), eflusilanato, DDT, metoxicloro; Agonistas / antagonistas del receptor nicotinérgico de acetilcolina [II-4]: (II-4.A) Cloronicotinilos, por ejemplo, acetamiprid, clotianidina, dinotefuran, imidacloprid, imidaclotiz, nitenpiram, nitiazina, tiacloprid, tiametoxam; (II-4.B) nicotina, bensultap, cartap, tiosulfap-sodio, tiocilam; Moduladores del receptor alostérico de acetilcolina (agonistas) [II-5]: (II-5) Espinosinas, por ejemplo, espinosad, espinetoram; Activadores del canal de cloruro [II-6]: (II-6) Mectinas / Macrólidos, por ejemplo, abamectina, emamectina, benzoato de emamectina, ivermectina, lepimectina, milbemectina; (II-7.A) Análogos de la hormona juvenil, por ejemplo, hidropreno, quinopreno, metopreno, epofenonano, tripreno; (II-7.B) fenoxicarb; (II-7.C) piriproxifen, diofenolan; Principios activos con mecanismos de acción desconocidos o no específicos [II-8]: (II-8) Fumigantes, por ejemplo, bromuro de metilo, cloropicrina, fluoruro de sulfurilo; (II-9) Inhibidores selectivos de la alimentación, por ejemplo, criolita, pimetrozina, pirifluquinazona (NNI0101), flonicamid; (II-10) Inhibidores del crecimiento de los ácaros, por ejemplo, clofentezina, hexitiazox, etoxazol; Inhibidores de la fosforilación oxidativa, disruptores de ATP [II-12]: (II-12.A) Diafentiuron; (II-12.B) Compuestos orgánicos de estaño, por ejemplo, azociclotina, cihexatina, óxido de fenbutatina; (II-12.C) propargita, tetradifon; Desacopladores de la fosforilación oxidativa mediante interrupción del gradiente de protones H [II-13]: clorfenapir, binapacir1, dinobuton, dinocap, DNOC; (II-14) Disruptores microbianos de la membrana digestiva de los insectos cepas de Bacillus thuringiensis; Inhibidores de la biosíntesis de quitina [II-15]: (II-15) Benzoilureas, por ejemplo, bistrifluron, clorfluazuron, diflubenzuron, fluazuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron, triflumuron; (II-16) buprofezina; (II-17) Principios activos perturbadores de la muda; Agonistas/disruptores de ecdisona [II-18]: (II-18.A) Diacilhidrazina, por ejemplo, cromafenozida, halofenozida, metoxifenozida, tebufenozida, fufenozida (JS-118), (II-18.B) Azadiractina; Agonistas octopaminérgicos, por ejemplo, (II-19) amitraz; Inhibidores del transporte de electrones del sitio III / inhibidores del transporte de electrones del sitio II [II-20]: (II-20.A) Hidrametilnona, (II-20.B) Acequinocilo, (II-20.C) Fluacripirirn, (II-20.D) Ciflumetofen, cienopirafen; Inhibidores del transporte de electrones; [11-21] Inhibidores del transporte de electrones del sitio I del grupo de los acaricidas METI, por ejemplo, fenazaquin, fenpiroximato, pirimidifen, piridaben, tebufenpirad, tolfenpirad, rotenona; Bloqueadores del canal de sodio dependientes del voltaje [II-22], por ejemplo, (I-22.A) indoxacarb, por ejemplo, (II-22.B) metaflumizona (BAS 3201); Inhibidores de la biosíntesis de ácidos grasos [II-23]: (II-23.A) Derivados de ácido tetrónico, por ejemplo, espirodiclofen, espiromesifen; (II-23.B) Derivados de ácido tetrámico, por ejemplo, espirotetramato; [II-25] Inhibidores neuronales con mecanismo de acción desconocido, Bifenazato; Efectores del receptor de rianodina; Diamidas [II-28], por ejemplo, flubendiamida de fórmula (2), Clorantraniliprol (rinaxipir), Ciantraniliprol (ciazipir, de fórmula (3)); [II-29] Principios activos con mecanismo de acción desconocido, amidoflumet, benclotiaz, benzoximato, bromo-propilato, buprofezina, quinometionato, clordimeform, clorobenzilato, clortiazoben, ciclopreno, dicofol, diciclanilo, fenoxacrim, fentrifanilo, flubencimina, fluensulfona (5-cloro-2-[(3,4,4-trifluorobut-3-en-1-il)sulfonil]-1,3-tiazol), flufenerim, flutenzina, gossiplure, japonilure, metoxa-diazona, petróleo, oleato de potasio, piridalilo, sulfluramida, tetrasul, triarateno, verbutina, otros preparados a base de Bacillus firmus (I-1582, BioNeem, Votivo), 4-{[(6-cloropirid-3-il)metil](metil)amino}furan-2(5H)-ona (conocido del documento EP-A-0 539 588) de fórmula (4), 4-{[(6-cloropirid-3-il)metil](2,2-difluoretil)amino}furan-2(5H)-ona (conocido del documento WO 2007/115644) de fórmula (5), 4-{[(6-cloropirid-3-il)metil](ciclopropil)amino}furan-2(5H)-ona (conocido del documento EP-A-0 539 588) de fórmula (6), 1-{2-fluoro-4-metil-5-[(2,2,2-trifluoroetil)sulfinil]fenil}-3-(trifluorometil)-1H-1,2,4-triazol-5-amino (conocido del documento WO 2006/043635) y sulfoxaflor.The compounds herein possess effective insecticidal and acaricidal properties against animal parasites. Claim 1: Combinations of active ingredients containing at least one compound, and preferably exactly one, of the formula (1), wherein (the) G¹ represents N, CH or C-halogen, G² represents a remainder of formula (A ), where R¹ represents hydrogen or alkyl and G³ represents heterocyclyl if substituted, heteroaryl if substituted or aryl, if substituted or (Ib) G¹ represents N or C-halogen, G² represents the rest of formula (B ), where G³ represents heterocyclyl if substituted, heteroaryl if substituted or aryl, if substituted, or (Ic) G¹ represents CH, G² represents the rest of formula (B), where G³ represents given heterocyclyl the substituted case or furanyl, if the case substituted or represents thienyl substituted by halogen, nitro, amino, alkylamino, dialkylamino, haloalkyl, cycloalkylalkyl, alkoxy, haloalkoxy, alkylthio, alkoxyalkyl, bis (alkoxy) alkyl, alkoxycarbonyl, α-hydrox imino-alkoxycarbonylmethyl, a-alkoxymethyl-alkoxycarbonylmethyl, C (X) NR²R³ (where X represents oxygen or sulfur, R² represents hydrogen or alkyl and R³ represents alkyl, haloalkyl, alkoxy, cyanoalkyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkylthio or arylalkyl or R² and R³, together with the nitrogen atom to which they are attached, form a ring), alkylsulfinyl, alkylsulfonyl, heterocyclyl, aryl (which, in turn, may be substituted with halogen, cyano, nitro, alkyl and haloalkyl ), heteroaryl (which, in turn, may be substituted with halogen, nitro, alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl, alkylthio, alkylthioalkyl and cycloalkyl), heteroarylalkyl (which, in turn, may be substituted with halogen, nitro , alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl, alkylthio, alkylthioalkyl and cycloalkyl), substituted thienyl or represents hetaryl, where appropriate in each case of the pirro series lilo, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl, 1,3, 4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl, benzofuryl, bencisofuryl, benzothienyl, bencisothienyl, indolyl, isoindolyl, indazolyl, benzothiazolyl, bencisothiazolyl, benzoxazolyl, benzyloxazolyl 2 , 1,3-benzoxadiazole, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, benzotriazinyl, purinyl, pteridinyl and indolizinyl or represents aryl substituted with cyano, nitro, haloalkoxy or N-heterocyclyl, or CH id or C-halogen, G² represents a residue of formula (C), in which R¹ represents hydrogen or alkyl and G³ represents heterocyclyl, if substituted, heteroary ilo given the substituted case or aryl given the substituted case, or as well as salts, metal complexes and N-oxides of the compounds of formula (1), and one or more other active ingredients of the group (of the formula) (II) as shown below: Acetylcholinesterase (AChE) [II-1] inhibitors: (II-1.A) Carbamates, for example, alanicarb, aldicarb, aldoxicarb, alixicarb, aminocarb, bendiocarb, benfuracarb, bufencarb, butacarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Cloetocarb, Dimethylan, Etiofencarb, Phenobucarb, Phenothiocarb, Formetanato, Furatiocarb, Isoprocarb, Metam-Sodium, Methiocarb, Methomyl, Metolcarb, Oxycarbamide, Pyroxycarbamide, Pyroxycarbamide, Pyroxycarbamicide, Pyroxycarbamide, Pyroxycarbamide, Pyroxycarbamide, Pyroxycarbamide, Pyroxamide XMC, xylilcarb; (II-1.B) organophosphates, for example, acetate, azametifos, (methyl, ethyl) azinfos, ethyl bromofos, (methyl) bromfenvinfos, butathiophos, cadusafos, carbofenotion, chloretoxyphos, chlorfenvinfos, chlorormefos, (methyl, ethyl) chlorpyrifos, coumafos, cyanophenphos, cyanophos, chlorfenvinfos, demeton-S-methyl, demeton-S-methylsulfone, dialifos, diazinon, diclofention, dichlorvos / DDVP, dichrotophos, dimethoate, dimethylvinfos, di-oxabenzofos, disulfoton, EPN, etion, eprofos, epr famfur, fenamiphos, fenitrotion, fensulfotion, fention, flupirazofos, phonophos, formotion, fosmetilan, fostiazato, heptenofos, iodophenophos, iprobenfos, isazofos, isofenfos, isopropyl, O-salicylate, isoxation, mettion, methaphosamide, methion, methaphosamide, methaphosamide, methionamide, methaphosamide, methamphoamide monocrotophos, naled, ometoate, methyl oxidemeton, (methyl, ethyl) paration, fentoate, forate, fosalon, fosmet, phosphamidon, phosphocarb, foxim, (methyl, ethyl) pyrimiphos, prophenophos, propaphos, propetamfos, protiophos, protoate, pyraclophos, piridation quin alfos, sebufos, sulfotep, sulprofos, tebupirimfos, temefos, terbufos, tetrachlorvinfos, tiometon, triazofos, trichlorfon, vamidotion; GABA-controlled chloride channel antagonists [II-2]: (II-2.A) Organochlorides, for example, canfechlor, chlordane, endosulfan, g-HCH, HCH, heptachlor, lindane, methoxychloro; (II-2.B) Fiproles (phenylpyrazoles), for example, acetoprol, ethiprole, fipronil, pyrafluprol, pyriprole, vanyliprol; Sodium channel modulators / tension-dependent sodium channel blocker [II-3]: (II-3) Pyrethroids, for example, acrinatrin, (d-cis-trans, d-trans) aletrine, b-ciflutrin, Biphentrine, bioaletrine, S-cyclopentyl isomer bioaletrine, bioethanometin, biopermethrin, bioresmethrin, clovaportrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocitrin, cycloprotrin, kyphlutrin, cyhalotrine, (a-, b- ) cypermethrin, cyphenothrin, deltamethrin, empenthrin (1R isomer), esfenvalerate, eto-fenprox, fenfluthrin, fenpropathrin, fenpiritrina, fenvalerate, flubrocitrinato, flucythrinate, flufenprox, flumethrin, fluvalinate, fub-fenprox, g-cyhalothrin, imiprothrin, kadethrin, l -cihalotrine, metoflutrin, (cis-, trans-) permethrin, phenotrin (1R-trans isomer), praletrin, proflutrin, protrifenbute, pyres-metrin, resmethrin, RU 15525, silafluophen, t-fluvalinate, teflutrin, teraletrine, tetrametrine 1R), tralometrine, transflutrin, ZXI 8901, pyrethrin (pi retrum), eflusilanato, DDT, methoxychloro; Nicotinergic acetylcholine receptor agonists / antagonists [II-4]: (II-4.A) Chloronicotinyls, for example, acetamiprid, clothianidine, dinotefuran, imidacloprid, imidaclotiz, nitenpiram, nitiazine, thiacloprid, thiamethoxam; (II-4.B) nicotine, bensultap, cartap, thiosulfap-sodium, thiocylam; Modulators of the allosteric acetylcholine receptor (agonists) [II-5]: (II-5) Spinosyns, for example, spinosad, spinetoram; Chloride channel activators [II-6]: (II-6) Mectins / Macrolides, for example, abamectin, emamectin, emamectin benzoate, ivermectin, lepimectin, milbemectin; (II-7.A) Juvenile hormone analogs, for example, hydroprene, quinoprene, metoprene, epophenone, triprene; (II-7.B) phenoxycarb; (II-7.C) pyriproxyfen, diofenolan; Active ingredients with unknown or non-specific mechanisms of action [II-8]: (II-8) Fumigants, for example, methyl bromide, chloropicrin, sulfuryl fluoride; (II-9) Selective feeding inhibitors, for example, cryolite, pimetrozin, pyrifluquinazone (NNI0101), flonicamid; (II-10) Mite growth inhibitors, for example, clofentezine, hexithiazox, ethoxazole; Oxidative phosphorylation inhibitors, ATP disruptors [II-12]: (II-12.A) Diafentiuron; (II-12.B) Organic tin compounds, for example, azocyclotin, cyhexatin, fenbutatin oxide; (II-12.C) propargite, tetradifon; Disconnectors of oxidative phosphorylation by interruption of the proton gradient H [II-13]: chlorfenapir, binapacir1, dinobuton, dinocap, DNOC; (II-14) Microbial disruptors of the digestive membrane of Bacillus thuringiensis strain insects; Inhibitors of chitin biosynthesis [II-15]: (II-15) Benzoylureas, for example, bistrifluron, chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, penifluronuronflibonuronfluronuronfluronuronfluronuronfluronuronfluronum (II-16) buprofezin; (II-17) Disturbing active principles of the molt; Ecdisone agonists / disruptors [II-18]: (II-18.A) Diacylhydrazine, for example, cromafenozide, halofenozide, methoxyphenozide, tebufenozide, fufenozide (JS-118), (II-18.B) Azadirachtin; Octopaminergic agonists, for example, (II-19) amitraz; Site III electron transport inhibitors / Site II electron transport inhibitors [II-20]: (II-20.A) Hydramethylnone, (II-20.B) Acequinocil, (II-20.C) Fluacripirirn, (II-20.D) Ciflumetofen, cienopirafen; Inhibitors of electron transport; [11-21] Electron transport inhibitors from site I of the METI acaricide group, for example, fenazaquin, fenpyroximate, pyrimidiphen, pyridaben, tebufenpirad, tolfenpirad, rotenone; Voltage-dependent sodium channel blockers [II-22], for example, (I-22.A) indoxacarb, for example, (II-22.B) metaflumizone (BAS 3201); Inhibitors of fatty acid biosynthesis [II-23]: (II-23.A) Derivatives of tetronic acid, for example, spirodiclofen, spiromesifen; (II-23.B) Tetramic acid derivatives, for example, spirotetramate; [II-25] Neural inhibitors with unknown mechanism of action, Bifenazate; Ryanodine receptor effectors; Diamides [II-28], for example, flubendiamide of formula (2), Chlorantraniliprol (rinaxipir), Ciantraniliprol (ciazipir, of formula (3)); [II-29] Active ingredients with unknown mechanism of action, amidoflumet, benclothiaz, benzoximate, bromo-propylate, buprofezin, quinomethionate, clordimeform, chlorobenzylate, chlortiazoben, cycloprene, dicofol, diciclanil, phenoxacrim, phetrifanil, flubencimulfine -2 - [(3,4,4-trifluorobut-3-en-1-yl) sulfonyl] -1,3-thiazole), flufenerim, flutenzine, gossiplure, japonilure, metoxa-diazone, petroleum, potassium oleate, pyridalyl , sulfluramide, tetrasul, triaratene, verbutin, other preparations based on Bacillus firmus (I-1582, BioNeem, Votive), 4 - {[(6-chloropyrid-3-yl) methyl] (methyl) amino} furan-2 ( 5H) -one (known from EP-A-0 539 588) of formula (4), 4 - {[(6-chloropyrid-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 ( 5H) -one (known from WO 2007/115644) of formula (5), 4 - {[(6-chloropyrid-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (known from EP-A-0 539 588) of formula (6), 1- {2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl} -3- (trifluor omethyl) -1H-1,2,4-triazol-5-amino (known from WO 2006/043635) and sulfoxaflor.

ARP110101411A 2011-04-25 2011-04-25 SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES AR085172A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP110101411A AR085172A1 (en) 2011-04-25 2011-04-25 SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP110101411A AR085172A1 (en) 2011-04-25 2011-04-25 SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES

Publications (1)

Publication Number Publication Date
AR085172A1 true AR085172A1 (en) 2013-09-18

Family

ID=59676893

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101411A AR085172A1 (en) 2011-04-25 2011-04-25 SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES

Country Status (1)

Country Link
AR (1) AR085172A1 (en)

Similar Documents

Publication Publication Date Title
AR068624A1 (en) COMBINATIONS OF ACTIVE PRINCIPLES WITH INSECTICIDES AND ACARICIDES
AR066093A1 (en) PROCEDURE TO COMBAT PARASITES THROUGH COMBINATION OF INSECTICIDES AND TRANSGENIC PLANTS WITH APPLICATION TO LEAVES AND IN BREBAJES
AR071349A1 (en) COMBINATIONS OF ACTIVE PRINCIPLE THAT PRESENT INSECTICIDES AND ACARICIDES
AR071901A1 (en) COMBINATIONS OF ACTIVE COMPOUNDS THAT HAVE INSECTICIDES AND ACARICIDES PROPERTIES
ES2666415T3 (en) Insecticidal compounds based on isoxazoline derivatives
RU2010101111A (en) PESTICIDAL COMPOSITION CONTAINING A STIGOLACTONE DERIVATIVE AND INSECTICIDE COMPOUND
RU2014121094A (en) 1,3-DIARIL-SUBSTITUTED HETEROCYCLIC PESTICIDES
AR077182A1 (en) COMBINATIONS OF BIOLOGICAL CONTROL AGENTS AND INSECTICIDES
AR086588A1 (en) PESTICIDE MIXTURES THAT INCLUDE ISOXAZOLINIC DERIVATIVES
ES2543747T3 (en) Isoxazoline derivatives as insecticides
JP2009522282A5 (en)
TW200800018A (en) Hydrazide compound and pesticidal use of the same
TW200942170A (en) Aminobenzamide derivatives as useful agents for controlling animal parasites
BR112013000925A2 (en) heterocyclic compounds as pesticides
HUE027891T2 (en) 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
CN106866557B (en) (Z)-β-alkenyl bromine multicomponent prepares the method and application of 1,4- substitution -1,2,3- triazole
TWI771402B (en) Pyridone compound, and agricultural and horticultural fungicide using same as active ingredient
JPWO2014050894A1 (en) Ascorbic acid analogs and anti-plant virus agents
RU2018125940A (en) HETEROCYCLED BICYCLIC ASOL PESTICIDES
KR20170102359A (en) Antiparasitic compound
AR085172A1 (en) SYNERGIC COMBINATIONS OF ACTIVE PRINCIPLES
Vinicius Nora De Souza Stille reaction: An important tool in the synthesis of complex natural products
Busch-Petersen et al. A rhodium (II) catalytic approach to the synthesis of ethers of a minor component in a tautomeric set
US9073912B2 (en) Azetidine derivatives as antiparasitic agents
WO2011148886A1 (en) Noxious organism control agent

Legal Events

Date Code Title Description
FB Suspension of granting procedure